Oct 6, 2022 by Kody Kester2 Cheap Stocks That Could Help You Retire EarlyThese two companies are growing their revenue and earnings with each passing year.
Oct 4, 2022 by Kody KesterIs This High-Yielding Dividend Stock a Buy?Darden Restaurants offers income investors a near 4% dividend yield.
Oct 3, 2022 by Kody KesterCould This Biosimilar Drug Candidate Be a Hit for Novartis?Novartis recently announced encouraging results from its clinical trial of its Prolia biosimilar.
Oct 1, 2022 by Kody KesterWhat This News Means for MerckCancer drug Lynparza received an approval in China to treat patients with a type of ovarian cancer.
Oct 1, 2022 by Kody KesterHere's Why This Dividend King Is a BuyShares of this drugmaker have far outpaced the S&P 500 index in 2022.
Sep 30, 2022 by Kody KesterLooking to Rev Up Your Portfolio's Returns? Buy This Growth StockThis auto parts retailer is present in much of the U.S.
Sep 29, 2022 by Kody Kester2 Top Cannabis Stocks to Buy for the Long HaulFew industries can match the long-term growth catalysts of the cannabis industry. And these two companies are the most established landlords in the industry.
Sep 29, 2022 by Kody KesterThis Dominant Stock Is a Buy for Growth InvestorsHigh inflation is proving to be a boon for Costco.
Sep 28, 2022 by Kody KesterIs This Blue Chip Stock a Buy for Income Investors?General Mills' tremendous portfolio of brands positions it as one of the most prominent consumer staples companies in the world.
Sep 26, 2022 by Kody KesterShould You Buy This Recession-Proof Dividend Stock?Amid elevated inflation, dollar stores are helping consumers stretch their budgets further.
Sep 25, 2022 by Kody KesterThis Dividend-Paying Growth Stock Hit a Rough Patch. Is It Still a Buy?This company is a leading off-price retailer.
Sep 24, 2022 by Kody KesterThis Dividend King Is Showing Growth -- But Should You Really Buy?Hormel Foods is a longtime dividend payer with an incredible 56 consecutive years of increases.
Sep 24, 2022 by Kody KesterShould Growth Investors Buy This Little-Known Stock?Due to the downturn in the broader market, this genetic-testing stock has crashed so far this year.
Sep 23, 2022 by Kody KesterWhat Could This Drug News Mean for AbbVie?AbbVie recently submitted a regulatory application in the European Union for Rinvoq to treat patients with a form of inflammatory bowel disease.
Sep 23, 2022 by Kody KesterIs This Beaten-Down Growth Stock a Buy?The stock of this pet health insurer has done significantly worse than the Nasdaq Composite in recent months.
Sep 21, 2022 by Kody KesterIs This Value Stock a Buy for Income Investors?TJX Companies is a well-known discount retailer that can endure the current economic environment.
Sep 21, 2022 by Kody KesterIs This Blue Chip Dividend Stock a Buy?Williams-Sonoma is a digital-driven retailer that stands out in a fragmented global home-products industry.
Sep 19, 2022 by Kody Kester2 Biotech Stocks You Can Buy and Hold for the Next DecadeIt's hard to imagine a world in which pharmaceutical spending doesn't increase year in and year out.
Sep 18, 2022 by Kody Kester2 Best Healthcare Stocks to Buy Right NowThe healthcare sector typically performs well in all kinds of economic environments.
Sep 16, 2022 by Kody Kester3 Underrated Warren Buffett Stocks That Are Smart Buys Right NowEach of these companies has compelling trends on its side.